Literature DB >> 10191816

Directly observed therapy and tuberculosis treatment completion. Jereb et al. re: Bayer et al.

J A Jereb, P M Simone, I M Onorato.   

Abstract

Entities:  

Mesh：

Year:  1999        PMID： 10191816      PMCID： PMC1508875          DOI： 10.2105/ajph.89.4.603

Source DB:  PubMed          Journal:  Am J Public Health        ISSN： 0090-0036            Impact factor:   9.308


× No keyword cloud information.
  3 in total

1.  Nihilism and pragmatism in tuberculosis control.

Authors:  P Farmer; E Nardell
Journal:  Am J Public Health       Date:  1998-07       Impact factor: 9.308

2.  Directly observed therapy and treatment completion for tuberculosis in the United States: is universal supervised therapy necessary?

Authors:  R Bayer; C Stayton; M Desvarieux; C Healton; S Landesman; W Y Tsai
Journal:  Am J Public Health       Date:  1998-07       Impact factor: 9.308

3.  Preventing multidrug-resistant tuberculosis.

Authors:  A B Bloch; P M Simone; E McCray; K G Castro
Journal:  JAMA       Date:  1996-02-14       Impact factor: 56.272
  3 in total
  1 in total

1.  Directly observed therapy of sofosbuvir/ribavirin +/- peginterferon with minimal monitoring for the treatment of chronic hepatitis C in people with a history of drug use in Chennai, India (C-DOT).

Authors:  S S Solomon; M S Sulkowski; P Amrose; A K Srikrishnan; A M McFall; B Ramasamy; M S Kumar; S Anand; D L Thomas; S H Mehta
Journal:  J Viral Hepat       Date:  2017-08-14       Impact factor: 3.728
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.